The brokerage believe at current levels the market largely values Blue Jet based on its existing businesses, while assigning limited value to emerging opportunities.

The brokerage believe at current levels the market largely values Blue Jet based on its existing businesses, while assigning limited value to emerging opportunities.

Despite near-term margin headwinds, Tube India offers diversified revenue streams, with steady growth in the core business and CG Power, as well as the optionality of new businesses incubated under the TI-2 strategy, adds the brokerage.

BEL, Bharti Airtel, Dixon Tech, SBI, Titan, TVS Motor, BSE and more among Motilal Oswal Picks after stong Q1 earnings.

Execution across the lending, insurance and digital ecosystem is improving, enhancing visibility on consolidated earnings and intrinsic value compounding over the medium term, adds the brokerage.

Overall, Motilal Oswal's Q1 review remains tilted toward Buy recommendations, with the strongest percentage upside seen in Brigade Enterprises and Fujiyama Power Systems at around 41% each, followed by Max Healthcare and Aditya Birla Real Estate at around 40%.

Considering the front-loading of opex in new business initiatives like Enzene CDMOs and enhanced efforts to improve profitability of med-tech business, the brokerage expects Alkem's earnings to decline in FY27 and subsequently revive FY28 onward.

JLR volumes were impacted by temporary supply constraints, including a fire at a major component supplier at the start of the quarter, resulting in a 10% YoY decline, adds the brokerage.

Among the 10 stocks, Gokaldas Export carries the highest indicated upside of 46%, followed by Laxmi Dental at 40%, VIP Industries at 39%, based on the market prices cited in Motilal Oswal's reports.

Grasim's reported performance was above the brokerage's estimates, driven by lower than-estimated losses in the paints and B2B businesses, while chemical outperformance was offset by lower VSF profitability.

Given the better-than-expected performance in Q1, the brokerage has raised its earnings estimates on Tata Motors CV by 6%/2% for FY27/FY28.

HAL has received seven GE F404 engines till date and targets to commence deliveries of Tejas Mk1A aircrafts soon, with the first jet targeted for Aug-Sep'26, highlights the brokerage.

Target prices were raised for Vodafone Idea, Bosch and Amara Raja after their quarterly updates, while Triveni Turbine's target was cut following weaker-than-expected margins.

The capital goods major's margins across segments were impacted by commodity and currency fluctuations, especially in smart infrastructure, as a larger part of the order book is short cycle in nature, adds the brokerage.

Motilal Oswal has maintained its Buy rating on Shaily Engineering with a target price of Rs 4,074 implying a potential upside of 21% from the current levels.

Brokerage commentary suggests that while near-term challenges persist in certain segments, all three companies remain well positioned to capitalise on industry-specific opportunities, ranging from export recovery and premiumisation to capacity expansion and rising industrial demand.

Gland Pharma's adjusted profit increased 47% YoY to Rs 317 crore, aided by operating leverage and healthy growth in key overseas markets, adds the brokerage.

Higher energy and input costs weighed on Q1 margins, prompting Motilal Oswal to cut FY27 earnings estimates, though the brokerage remains positive on Bharat Forge's long-term defence and aerospace growth opportunities.

Among the five, the reports indicate the highest potential upside for Kirloskar Oil Engines at around 30%, followed by GR Infraprojects at 26%, Inox Wind and Premier Energies at around 18% each, and Mrs Bectors at 16%.

Kaynes revenue jumped 41% YoY in Q1, core EMS business grew 48%, and Motilal Oswal sees OSAT and PCB ventures emerging as key growth drivers while retaining a Buy rating.

The lender reported a net profit of Rs 21,120 crore for Q1 FY27, up 10.2% YoY and around 15% ahead of Motilal Oswal's estimates, supported by healthy treasury income and controlled operating expenses.